Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
Open Access
- 9 March 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (16) , 22650-22664
Abstract
Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancerKeywords
This publication has 49 references indexed in Scilit:
- Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stressEMBO Molecular Medicine, 2012
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological MalignanciesCell Stem Cell, 2011
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of MetastasisClinical Cancer Research, 2010
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheresMolecular Cancer, 2010
- The Emerging Role of the RAB25 Small GTPase in CancerTraffic, 2009
- Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical studyBMC Cancer, 2008
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersNature Medicine, 2004
- Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987